# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 2731 results.
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
Status: Recruiting
Last Changed: Dec 20, 2019
First Received: Jun 17, 2019
Disease(s): Acute Myeloid Leukemia
Locations: Soroka Medical Center /ID# 213369, Be'er Sheva, HaDarom, Israel
Assuta Medical Centers /ID# 213371, Tel Aviv, HaMerkaz, Israel
Rabin Medical Center /ID# 213343, Petakh Tikva, Tel-Aviv, Israel
Ha'Emek Medical Center /ID# 213370, Afula, Israel
Bnai Zion Medical Center /ID# 213344, Haifa, Israel
... and 4 other locations.
Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia
Status: Active, not recruiting
Last Changed: Oct 15, 2019
First Received: Jun 22, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): NK Cells + Chemotherapy Starting
Locations: Centro Terapia e Tecnologia Celular, Porto Alegre, Rio Grande Do Sul, Brazil
Role of PTK-7 in Acute Myeloid Leukemias
Status: Completed
Last Changed: Aug 10, 2016
First Received: Aug 09, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): Bone marrow aspiration, Blood sampling
Locations: Institut Paoli Calmettes, Marseille, Bouches du Rhone, France
IA14 Induction in Young Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Oct 15, 2019
First Received: Aug 28, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Idarubicin and cytarabine induction
Locations: Xinxin Cao, Beijing, Beijing, China
Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Active, not recruiting
Last Changed: May 23, 2018
First Received: Dec 18, 2014
Disease(s): Acute Myeloid Leukemia
Intervention(s): Azacitadine, Fludarabine, Cytarabine, Lenograstim, Filgastrim
Locations: Hospital Universitari i Politècnic La Fe, Valencia, Spain
Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia
Status: Active, not recruiting
Last Changed: Jan 27, 2020
First Received: Sep 30, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): guadecitabine, Treatment Choice (TC)
Locations: University of Southern California, Los Angeles, California, United States
The University of Chicago Medical Center, Chicago, Illinois, United States
Franciscan Research Center, Indianapolis, Indiana, United States
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
University of New Mexico School of Medicine, Albuquerque, New Mexico, United States
... and 91 other locations.
SEL24/MEN1703 in Patients With Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Oct 04, 2019
First Received: Jan 02, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): SEL24/MEN1703
Locations: Northside Hospital, Atlanta, Georgia, United States
Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio, United States
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
... and 1 other locations.
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
Status: Active, not recruiting
Last Changed: Mar 09, 2020
First Received: Nov 29, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): Standard Leukemia Care, Palliative Care
Locations: Massachusetts general Hospital, Boston, Massachusetts, United States
Duke University, Durham, North Carolina, United States
Ohio State University, Columbus, Ohio, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients
Status: Recruiting
Last Changed: Nov 19, 2019
First Received: Nov 19, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): rhTPO
Locations: ShengJing Hospital of China Medical University, Shenyang, Liaoning, China
Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients
Status: Unknown status
Last Changed: Apr 21, 2015
First Received: Jun 28, 2013
Disease(s): Acute Myeloid Leukemia
Intervention(s): Idarubicin
Locations: Bing Xu, GuangZhou, Guangdong, China